Enhancing delivery of small molecule and cell-based therapies for ovarian cancer using advanced delivery strategies

Ovarian cancer is the most lethal gynecological malignancy with a global five-year survival rate of 30-50%. First-line treatment involves cytoreductive surgery and administration of platinum-based small molecules and paclitaxel. These therapies were traditionally administered via intravenous infusio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Adv Ther (Weinh)
Auteurs principaux: O’Dwyer, Joanne, O’Cearbhaill, Roisin E., Wylie, Robert, O’Mahony, Saoirse, O’Dwyer, Michael, Duffy, Garry P., Dolan, Eimear B.
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7942751/
https://ncbi.nlm.nih.gov/pubmed/33709016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adtp.202000144
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires